Assignee

SAMUMED LLC

US·110 granted patents·7 pending applications·2,127 citations·filing 2013–2020

Technology mixC07D111 A61K98 A61P92 C07B16 C07C7 A61Q2

Top patents by PatentIndex Score

117 records

0199US9844536B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Dec 19, 2017·49 cites·37 claims
0299US9828372B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 28, 2017·49 cites·36 claims
0399US9763951B23-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·36 claims
0499US9763927B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·26 claims
0599US9586977B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Mar 7, 2017·49 cites·22 claims
0699US9381192B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jul 5, 2016·49 cites·47 claims
0799US9233104B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 12, 2016·67 cites·28 claims
0899US9199991B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Dec 1, 2015·70 cites·38 claims
0999US8987298B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 24, 2015·77 cites·79 claims
1099US8901150B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Dec 2, 2014·77 cites·30 claims
1199US8703794B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Apr 22, 2014·81 cites·20 claims
1299US8697887B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2013·Granted Apr 15, 2014·104 cites·23 claims
1399US8673936B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 18, 2014·85 cites·28 claims
1499US8664241B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 4, 2014·83 cites·30 claims
1599US8618128B11H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 31, 2013·84 cites·30 claims
1699US8604052B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 10, 2013·92 cites·18 claims
1798US10407425B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2018·Granted Sep 10, 2019·15 cites·18 claims
1898US9889140B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Feb 13, 2018·23 cites·36 claims
1998US9855272B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Jan 2, 2018·44 cites·17 claims
2098US9815854B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 14, 2017·49 cites·37 claims
2198US9802916B2Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2015·Granted Oct 31, 2017·52 cites·3 claims
2298US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
2398US9540398B23-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 10, 2017·33 cites·32 claims
2498US9090613B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jul 28, 2015·84 cites·23 claims
2598US9067939B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jun 30, 2015·75 cites·18 claims
2698US9012472B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Apr 21, 2015·73 cites·77 claims
2798US8883822B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Nov 11, 2014·76 cites·16 claims
2898US8846714B21H-pyrazolo[3,4-β]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Sep 30, 2014·82 cites·32 claims
2997US10981909B2Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamideSAMUMED LLC·Filed 2020·Granted Apr 20, 2021·8 cites·22 claims
3097US10947228B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·9 cites·36 claims
3197US10131677B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2017·Granted Nov 20, 2018·15 cites·32 claims
3296US9994563B2Indazole inhibitors of the wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jun 12, 2018·7 cites·5 claims
3396US9795550B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2015·Granted Oct 24, 2017·12 cites·38 claims
3495US9951048B1Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Apr 24, 2018·13 cites·30 claims
3595US8629176B1β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Jan 14, 2014·17 cites·14 claims
3694US10434052B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2017·Granted Oct 8, 2019·3 cites·18 claims
3794US10287267B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted May 14, 2019·7 cites·30 claims
3894US9908867B23-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 6, 2018·20 cites·8 claims
3994US8921413B2β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Dec 30, 2014·14 cites·15 claims
4094US8815897B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Aug 26, 2014·82 cites·65 claims
4193US10947217B2Isoquinolin-3-YL carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·4 cites·40 claims
4293US9884053B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2016·Granted Feb 6, 2018·7 cites·42 claims
4393US9303010B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Apr 5, 2016·12 cites·11 claims
4491US9738638B22-(1H-indazol-3-yl)-3H-imidazo[4,5-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Aug 22, 2017·4 cites·31 claims
4591US9493437B2β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
4691US9493487B23-(1H-imidazo[4,5-C]pyridin-2-YL)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Nov 15, 2016·4 cites·31 claims
4791US9475807B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Oct 25, 2016·5 cites·32 claims
4890US10899757B22-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereofSAMUMED LLC·Filed 2016·Granted Jan 26, 2021·8 cites·8 claims
4990US10464924B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2017·Granted Nov 5, 2019·5 cites·37 claims
5090US9533976B2γ-diketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Jan 3, 2017·9 cites·3 claims

Showing the top 50 of 117 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when SAMUMED LLC files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →